Riskpilot← Back to searchSign inGet full accessHälsodesign Sverige AB
ABActiveOrg 5591779466Rörmossevägen 130Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20181 employees
Revenue 2025
SEK 989K
+26% vs 2024
EBITDA margin
14.5%
+41% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
SEK 115K
+33% vs 2024
| Revenue | SEK 989K | +26% |
| EBITDA | SEK 144K | +41% |
| Net profit | SEK 115K | +33% |
| Total assets | SEK 593K | +13% |
| Equity | SEK 396K | +41% |
| Employees | 1 | — |
Legal name
Hälsodesign Sverige AB
Org number
5591779466
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 november 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva försäljning- uthyrning samt utbildning inom medicinsk utrustning samt leverantör inom privat- företagsleasing och därmed förenlig verksamhet. Bolaget kommer även arbeta med att bygga försäljningsorganisationer och utbildning inom området.
Address
Rörmossevägen 130
Email
mikael.andersson@bemermail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 647 | 736 | 595 | 783 | 989 |
| Staff expenses | — | −363 | −423 | −418 | −511 |
| EBITDA | 15 | 98 | 20 | 102 | 144 |
| Depreciation & amort. | −6 | −6 | −6 | — | — |
| EBIT | 9 | 92 | 14 | 102 | 144 |
| Net financials | — | 0 | 4 | 5 | 1 |
| Profit before tax | 10 | 92 | 130 | 107 | 144 |
| Tax | −2 | −19 | −28 | −22 | −30 |
| Net profit | 8 | 72 | 102 | 86 | 115 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 751 | 788 | 442 | 523 | 593 |
| Equity | 521 | 594 | 296 | 282 | 396 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 118 | 82 | 147 | 242 | 197 |
| Total debt | 118 | 82 | 147 | 242 | 197 |
EBITDA margin
14.5%
This company
15.8%
Market median
-8% vs market
20212025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20212025
Return on equity
28.9%
This company
18.4%
Market median
+57% vs market
20212025
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20212025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20212025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsodesign Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Mikael Ekfeldt | Board of Directors | 0 companies |
| Charlotte Margareta Ekfeldt | Deputy Board Member | 0 companies |